Non-sentinel lymph node status and prognosis of breast cancer patients with micrometastatic sentinel lymph nodes

European Surgical Research

Volumn 45, Issue 3-4, 2010, Pages 344-349

  Onishi, T ^a   Jinno, H ^a   Takahashi, M ^a   Hayashida, T ^a   Sakata, M ^a   Nakahara, T ^a   Shigematsu, N ^a   Mukai, M ^a   Kitagawa, Y ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Micrometastasis; Prognosis; Sentinel lymph node

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAXANE DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 78349267240     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321709     Document Type: Article

References (31)

1. Nemoto T, Natarajan N, Bedwani R, Vana J, Murphy GP: Breast cancer in the medial half. Results of 1978 National Survey of the American College of Surgeons. Cancer 1983; 51: 1333-1338.
2. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-187.
3. Hoe AL, Iven D, Royle GT, Taylor I: Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 1992; 79: 261-262.
4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
5. Saphir O, Amormin G: Obscure axillary lymph-node metastasis in carcinoma of the breast. Cancer 1948; 1: 238-341.
6. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350.
7. Groen RS, Oosterhuis AW, Boers JE: Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications. Breast Cancer Res Treat 2007; 105: 1-5.
8. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE: Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 1999; 6: 756-761.
9. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE, ALMANAC Trialists Group: Predictors of nonsentinel lymph node metastasis in breast cancer patients. Eur J Cancer 2004; 40: 1731-1737. (Pubitemid 38902909)
10. Stitzenberg KB, Meyer AA, Stern SL, Cance WG, Calvo BF, Klauber-DeMore N, Kim HJ, Sansbury L, Ollila DW: Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg 2003; 237: 607-613.
11. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229: 536-541.
12. Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, Lucas PC, Snyder ML, Chang AE, Newman LA: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 2003; 98: 2307-2315.
13. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999; 17: 1720-1726.
14. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, Giuliano AE: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89: 574-581.
15. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, Renne G, Pruneri G, Maisonneuve P, Veronesi U: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001; 92: 1378-1384.
16. Rutledge H, Davis J, Chiu R, Cibull M, Brill Y, McGrath P, Samayoa L: Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 2005; 18: 762-768.
17. de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, Nortier JW, Rutgers EJ, Seynaeve C, Menke-Pluymers MB, Bult P, Tjan-Heijnen VC: Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009; 361: 653-663.
18. Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, Sim MS, Giuliano AE: Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 2009; 27: 4679-4684.
19. Jinno H, Ikeda T, Matsui A, Kitagawa Y, Kitajima M, Fujii H, Nakamura K, Kubo A: Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes. Biomed Pharmacother 2002; 56: 213s- 216s.
20. Jinno H, Ikeda T, Asaga S, Muto T, Kitagawa Y, Fujii H, Mukai M, Kitajima M: Increasing age does not affect efficacy of sentinel lymph node biopsy using smaller-sized technetium- 99m tin colloids for breast cancer patients. Am J Surg 2005; 190: 51-54.
21. Nos C, Harding-MacKean C, Fréneaux P, Trie A, Falcou MC, Sastre-Garau X, Clough KB: Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 2003; 90: 1354-1360.
22. Langer I, Marti WR, Guller U, Moch H, Harder F, Oertli D, Zuber M: Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005; 241: 152-158.
23. Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, O'Connell TX: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003; 138: 52-56.
24. Fant JS, Grant MD, Knox SM, Livingston SA, Ridl K, Jones RC, Kuhn JA: Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003; 10: 126-130.
25. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R: Tenyear results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-681.
26. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152: 765-772.
27. Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I: Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 1996; 74: 820-824.
28. Baum M, Vaidya JS, Mittra I: Multicentricity and recurrence of breast cancer. Lancet 1997; 349: 208.
29. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241.
30. Janni W, Hepp F, Rjosk D, Kentenich C, Strobl B, Schindlbeck C, Hantschmann P, Sommer H, Pantel K, Braun S: The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence. Cancer 2001; 92: 46-53. (Pubitemid 32623039)
31. Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, Luini A, Intra M, Veronesi P, Galimberti V, Torrisi R, Cardillo A, Goldhirsch A, Viale G: Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 2005; 23: 1379-1389.